Beth C Seidenberg sold $585K of Vera Therapeutics (VERA)

Executed Sep 19 2024, disclosed Sep 20 2024, 1 day later.

Value, as filed

$585K

13,823 sh × $42.31

Executed

Sep 19 2024

the trade date, as filed

Disclosed

Sep 20 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BS Beth C Seidenberg Director profile →

Beth C Seidenberg (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in KYTX. Across 1 priced purchase filing, the average 21-session return was +27.4% from execution and +44.4% from disclosure (delay-adjusted; derived). The largest single filing was $1000K of KYTX (133,333 sh × $7.50, as filed), executed Dec 18 2025.

The name

VERA Vera Therapeutics, Inc. VERA · Healthcare · 30 filings in 24 months ticker →

Healthcare · Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatme…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Beth C Seidenberg in VERA

VERASALE Vera Therapeutics, Inc. $710K
14,798 sh × $48.01
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET